New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

面对前列腺癌这一男性泌尿系统高发肿瘤，传统雄激素剥夺治疗 (ADT)虽是基石，但"大多数患者在接受ADT后约1年内进展为去势抵抗性前列腺癌" [1]。近年来，新型内分泌治疗药物的问世为临床带来革命性突破，显著延长患者生存期并改善生活质量。

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

An article about the importance of PSA testing for early detection and treatment of prostate cancer ...